Literature DB >> 16113813

The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates.

Lisa E Hensley1, Thomas W Geisbert.   

Abstract

Recently, there have been substantial developments in the understanding of Ebola hemorrhagic fever pathogenesis, but there are still major gaps. These infections occur in underdeveloped areas of the world, and much of our knowledge of naturally occurring disease is derived from sporadic outbreaks that occurred decades in the past. Recently conducted laboratory animal studies have provided insight into Ebola pathogenesis and may help guide clinical investigations of disease using contemporary methodologies that were not available previously. A better understanding of the relevant host and viral factors that influence clinical and virologic outcome will be critical to our ability to combat this aggressive pathogen. This article reviews the most relevant information relating to the postulated pathogenesis of this disease, focusing on the role of the endothelium in contributing to the coagulation disorders that characterize Ebola hemorrhagic fever in primates. Some of the remaining and key unanswered questions relating to the role of the vascular system in the pathogenesis of this disease, that need to be addressed in further research, are highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113813     DOI: 10.1160/TH05-03-0153

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus.

Authors:  Hideki Ebihara; Barry Rockx; Andrea Marzi; Friederike Feldmann; Elaine Haddock; Douglas Brining; Rachel A LaCasse; Don Gardner; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease.

Authors:  Reed F Johnson; Lori E Dodd; Srikanth Yellayi; Wenjuan Gu; Jennifer A Cann; Catherine Jett; John G Bernbaum; Dan R Ragland; Marisa St Claire; Russell Byrum; Jason Paragas; Joseph E Blaney; Peter B Jahrling
Journal:  Virology       Date:  2011-10-19       Impact factor: 3.616

3.  Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome.

Authors:  Rima Benferhat; Thibaut Josse; Benoit Albaud; David Gentien; Zeyni Mansuroglu; Vasco Marcato; Sylvie Souès; Bernard Le Bonniec; Michèle Bouloy; Eliette Bonnefoy
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 4.  Microbial induction of vascular pathology in the CNS.

Authors:  Silvia S Kang; Dorian B McGavern
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-18       Impact factor: 4.147

5.  Shed GP of Ebola virus triggers immune activation and increased vascular permeability.

Authors:  Beatriz Escudero-Pérez; Valentina A Volchkova; Olga Dolnik; Philip Lawrence; Viktor E Volchkov
Journal:  PLoS Pathog       Date:  2014-11-20       Impact factor: 6.823

6.  Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.

Authors:  Stuart D Dowall; Frédéric Jacquot; John Landon; Emma Rayner; Graham Hall; Caroline Carbonnelle; Hervé Raoul; Delphine Pannetier; Ian Cameron; Ruth Coxon; Ibrahim Al Abdulla; Roger Hewson; Miles W Carroll
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

Review 7.  Review: Viral infections and mechanisms of thrombosis and bleeding.

Authors:  M Goeijenbier; M van Wissen; C van de Weg; E Jong; V E A Gerdes; J C M Meijers; D P M Brandjes; E C M van Gorp
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

Review 8.  Ebola virus disease in nonendemic countries.

Authors:  Samson Sai-Yin Wong; Sally Cheuk-Ying Wong
Journal:  J Formos Med Assoc       Date:  2015-04-13       Impact factor: 3.282

Review 9.  The Baboon (Papio spp.) as a model of human Ebola virus infection.

Authors:  Donna L Perry; Laura Bollinger; Gary L White
Journal:  Viruses       Date:  2012-10-23       Impact factor: 5.048

10.  Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus.

Authors:  Mohammad F Saeed; Andrey A Kolokoltsov; Alexander N Freiberg; Michael R Holbrook; Robert A Davey
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.